DBD-F induces apoptosis in gastric cancer-derived cells through suppressing HIF2α expression

Guang-Hui Tong1, Wei-Wei Tong1, Xiao-Song Qin1

  • 1Department of Laboratory Medicine, ShengJing Affiliated Hospital, China Medical University, Shenyang, 110004, China.

Abstract

Insights

The novel compound DBD-F demonstrates significant anti-cancer properties against human gastric cancer cells. It effectively induces apoptosis and inhibits tumor growth by targeting HIF2α expression through the MEK/ERK pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Gastric cancer is a leading cause of cancer death in China.
  • Hypoxia-inducible factor 2 alpha (HIF2α) is implicated in gastric cancer aggressiveness.
  • Benzoxadiazole antagonists can interact with HIF2α.

Purpose of the Study:

  • To investigate the anti-tumor effects of 4-(N,Ndimethylaminosulphonyl)-7-fluoro-1,2,3-benzoxadiazole (DBD-F) on human gastric cancer cells.
  • To explore the mechanism of action of DBD-F, including its effect on HIF2α expression and related signaling pathways.

Main Methods:

  • In vitro assays using human gastric cancer cell lines (MKN28 and MKN45).
  • In vivo studies using gastric cancer-derived xenograft models.
  • Analysis of apoptosis, cell mobility, tumor growth, and HIF2α expression.

Main Results:

  • DBD-F induced apoptosis and inhibited mobility in gastric cancer cells in vitro.
  • DBD-F suppressed tumor growth in vivo xenograft models.
  • DBD-F inhibited HIF2α expression in gastric cancer cells.

Conclusions:

  • DBD-F exhibits cytotoxicity and induces apoptosis in gastric cancer cells.
  • DBD-F's mechanism involves the MEK/ERK signaling pathway.
  • DBD-F inhibits HIF2α expression by modulating MEK/ERK phosphorylation.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K